T1	tradename 0 6	BEXXAR
T2	activeingredient 8 19	tositumomab
T3	nanoparticle 24 49	iodine I 131 tositumomab)
T4	tradename 156 162	BEXXAR
T5	tradename 224 239	BEXXAR. BEXXAR
T6	activeingredient 241 252	tositumomab
T7	nanoparticle 257 282	iodine I 131 tositumomab)
T8	routeofadministration 298 309	intravenous
T9	fdaapprovaldate 342 346	2003
T10	adversereaction 535 554	Allergic Reactions:
T11	tradename 619 625	BEXXAR
T12	adversereaction 658 676	allergic reactions
T13	tradename 751 757	BEXXAR
T14	tradename 963 969	BEXXAR
T15	tradename 1580 1580	
T16	activeingredient 1582 1593	tositumomab
T17	nanoparticle 1598 1623	Iodine I 131 tositumomab)
T18	chemoclass 1629 1642	CD20-directed
T19	indication 1790 1811	nonHodgkin's lymphoma
T20	indication 1912 1935	non-Hodgkin's lymphoma.
T21	tradename 1984 1990	BEXXAR
T22	tradename 2136 2142	BEXXAR
T23	tradename 2235 2241	BEXXAR
T24	tradename 2439 2445	BEXXAR
T25	activeingredient 2641 2652	Tositumomab
T26	activeingredient 2714 2725	Tositumomab
T27	nanoparticle 2786 2810	Iodine I 131 tositumomab
T28	activeingredient 2841 2851	Iodine-131
T29	activeingredient 2924 2935	tositumomab
T30	nanoparticle 3007 3031	Iodine I 131 tositumomab
T31	activeingredient 3064 3074	Iodine-131
T32	activeingredient 3143 3154	tositumomab
T33	tradename 3576 3582	BEXXAR
T34	adversereaction 4215 4302	neutropenia, thrombocytopenia, anemia, infections, infusion reactions, asthenia, fever,
T35	adversereaction 4307 4314	nausea.
T36	company 4368 4383	GlaxoSmithKline
T37	tradename 6846 6852	BEXXAR
T38	tradename 6988 6994	BEXXAR
T39	tradename 7167 7173	BEXXAR
T40	tradename 7318 7324	BEXXAR
T41	tradename 7612 7618	BEXXAR
T42	tradename 7748 7754	BEXXAR
T43	tradename 8045 8051	BEXXAR
T44	indication 8177 8199	Non-Hodgkin's Lymphoma
T45	tradename 8205 8211	BEXXAR
T46	nanoparticle 8233 8244	tositumomab
T47	activeingredient 8249 8261	iodine I 131
T48	nanoparticle 8262 8274	tositumomab)
T49	indication 8399 8421	non-Hodgkin's lymphoma
T50	indication 8522 8545	non-Hodgkin's lymphoma.
T51	tradename 8590 8596	BEXXAR
T52	tradename 8742 8748	BEXXAR
T53	tradename 8844 8850	BEXXAR
T54	tradename 8985 8991	BEXXAR
T55	tradename 9100 9106	BEXXAR
T56	indication 9203 9226	non-Hodgkin's lymphoma.
T57	tradename 9266 9272	BEXXAR
T58	nanoparticle 9328 9339	tositumomab
T59	activeingredient 9347 9359	iodine I 131
T60	nanoparticle 9360 9372	tositumomab)
T61	nanoparticle 9810 9821	Tositumomab
T62	dose 9822 9828	450 mg
T63	routeofadministration 9832 9843	intravenous
T64	nanoparticle 9860 9877	I-131 tositumomab
T65	dose 9879 9890	5 mCi I-131
T66	routeofadministration 9913 9924	intravenous
T67	nanoparticle 10011 10022	Tositumomab
T68	dose 10023 10029	450 mg
T69	routeofadministration 10033 10044	intravenous
T70	nanoparticle 10062 10079	I-131 tositumomab
T71	dose 10081 10087	35 mg)
T72	routeofadministration 10091 10102	intravenous
T73	activeingredient 10117 10127	iodine-131
T74	activeingredient 10422 10432	Iodine-131
T75	activeingredient 10591 10601	Iodine-131
T76	nanoparticle 10701 10712	Tositumomab
T77	nanoparticle 10897 10908	tositumomab
T78	dose 10930 10936	450 mg
T79	nanoparticle 10937 10948	tositumomab
T80	nanoparticle 11148 11159	tositumomab
T81	nanoparticle 11277 11288	tositumomab
T82	nanoparticle 11411 11428	I-131 Tositumomab
T83	nanoparticle 11705 11722	I-131 tositumomab
T84	nanoparticle 11812 11829	I-131 tositumomab
T85	nanoparticle 12018 12035	I-131 tositumomab
T86	nanoparticle 12247 12264	I-131 tositumomab
T87	activeingredient 12539 12550	Iodine-131.
T88	nanoparticle 12787 12804	I-131 tositumomab
T89	nanoparticle 12919 12936	I-131 tositumomab
T90	nanoparticle 13070 13081	tositumomab
T91	nanoparticle 13182 13199	I-131 tositumomab
T92	nanoparticle 13326 13337	tositumomab
T93	nanoparticle 13420 13431	tositumomab
T94	nanoparticle 14544 14555	Tositumomab
T95	dose 14720 14726	450 mg
T96	nanoparticle 14727 14738	tositumomab
T97	routeofadministration 14772 14783	intravenous
T98	activeingredient 15314 15319	I-131
T99	nanoparticle 15320 15331	Tositumomab
T100	activeingredient 15383 15388	I-131
T101	nanoparticle 15389 15400	tositumomab
T102	activeingredient 15565 15570	I-131
T103	nanoparticle 15571 15582	tositumomab
T104	activeingredient 15644 15649	I-131
T105	nanoparticle 15650 15661	tositumomab
T106	nanoparticle 15723 15734	tositumomab
T107	activeingredient 16068 16073	I-131
T108	nanoparticle 16074 16085	tositumomab
T109	activeingredient 16676 16681	I-131
T110	nanoparticle 16682 16693	tositumomab
T111	activeingredient 16766 16778	Iodine I-131
T112	nanoparticle 16779 16790	tositumomab
T113	activeingredient 17043 17048	I-131
T114	nanoparticle 17053 17064	tositumomab
T115	company 17140 17155	GlaxoSmithKline
T116	nanoparticle 17367 17378	tositumomab
T117	company 19508 19523	GlaxoSmithKline
T118	tradename 19524 19530	BEXXAR
T119	company 19694 19709	GlaxoSmithKline
T120	activeingredient 19815 19825	Iodine-131
T121	nanoparticle 20011 20022	Tositumomab
T122	dose 20029 20035	450-mg
T123	nanoparticle 20044 20055	tositumomab
T124	nanoparticle 20146 20163	I-131 tositumomab
T125	nanoparticle 20401 20418	I-131 tositumomab
T126	nanoparticle 20511 20528	I-131 tositumomab
T127	activeingredient 20649 20654	I-131
T128	nanoparticle 20655 20667	tositumomab;
T129	activeingredient 20841 20846	I-131
T130	nanoparticle 20847 20858	tositumomab
T131	activeingredient 21033 21038	I-131
T132	nanoparticle 21039 21050	tositumomab
T133	activeingredient 21319 21330	Iodine-131.
T134	activeingredient 21600 21605	I-131
T135	nanoparticle 21606 21617	tositumomab
T136	activeingredient 21730 21735	I-131
T137	nanoparticle 21736 21747	tositumomab
T138	activeingredient 21796 21801	I-131
T139	nanoparticle 21806 21817	tositumomab
T140	nanoparticle 21911 21922	tositumomab
T141	activeingredient 22010 22015	I-131
T142	nanoparticle 22016 22027	tositumomab
T143	nanoparticle 22128 22139	tositumomab
T144	nanoparticle 22203 22214	tositumomab
T145	nanoparticle 22314 22325	tositumomab
T146	nanoparticle 22979 22990	Tositumomab
T147	dose 23144 23150	450 mg
T148	nanoparticle 23151 23162	tositumomab
T149	routeofadministration 23196 23207	intravenous
T150	activeingredient 23671 23676	I-131
T151	nanoparticle 23677 23688	Tositumomab
T152	activeingredient 23736 23741	I-131
T153	nanoparticle 23742 23753	tositumomab
T154	activeingredient 23912 23917	I-131
T155	nanoparticle 23918 23929	tositumomab
T156	activeingredient 23987 23992	I-131
T157	nanoparticle 23993 24004	tositumomab
T158	nanoparticle 24062 24073	tositumomab
T159	activeingredient 24412 24417	I-131
T160	nanoparticle 24418 24429	tositumomab
T161	activeingredient 25020 25025	I-131
T162	nanoparticle 25026 25037	tositumomab
T163	activeingredient 25110 25122	Iodine I-131
T164	nanoparticle 25123 25134	tositumomab
T165	activeingredient 25329 25334	I-131
T166	nanoparticle 25335 25346	tositumomab
T167	tradename 25684 25690	BEXXAR
T168	tradename 25804 25810	BEXXAR
T169	tradename 25853 25859	BEXXAR
T170	nanoparticle 26685 26696	Tositumomab
T171	nanoparticle 26749 26760	Tositumomab
T172	nanoparticle 26818 26829	tositumomab
T173	activeingredient 26860 26870	Iodine-131
T174	nanoparticle 26977 26988	tositumomab
T175	nanoparticle 27081 27092	tositumomab
T176	activeingredient 27125 27135	Iodine-131
T177	nanoparticle 27239 27250	tositumomab
T178	tradename 27465 27471	BEXXAR
T179	tradename 28030 28036	BEXXAR
T180	tradename 28163 28169	BEXXAR
T181	tradename 28317 28323	BEXXAR
T182	tradename 28731 28737	BEXXAR
T183	tradename 28965 28971	BEXXAR
T184	activeingredient 29001 29012	Iodine-131.
T185	tradename 29182 29188	BEXXAR
T186	tradename 29442 29448	BEXXAR
T187	tradename 29596 29602	BEXXAR
T188	tradename 29658 29664	BEXXAR
T189	tradename 29856 29862	BEXXAR
T190	tradename 30216 30222	BEXXAR
T191	tradename 30447 30453	BEXXAR
T192	tradename 30550 30556	BEXXAR
T193	tradename 31119 31125	BEXXAR
T194	tradename 31338 31344	BEXXAR
T195	tradename 31454 31460	BEXXAR
T196	tradename 31715 31721	BEXXAR
T197	tradename 31967 31973	BEXXAR
T198	tradename 32047 32053	BEXXAR
T199	activeingredient 32141 32160	radiolabeled iodine
T200	nanoparticle 32385 32403	I-131 tositumomab.
T201	tradename 32596 32602	BEXXAR
T202	tradename 32673 32679	BEXXAR
T203	tradename 32875 32882	BEXXAR.
T204	adversereaction 33033 33060	Serious Allergic Reactions,
T205	adversereaction 33071 33082	Anaphylaxis
T206	adversereaction 33151 33182	Prolonged and Severe Cytopenias
T207	adversereaction 33306 33320	Hypothyroidism
T208	tradename 33422 33428	BEXXAR
T209	adversereaction 33499 33537	neutropenia, thrombocytopenia, anemia,
T210	adversereaction 33542 33552	infections
T211	adversereaction 33564 33610	pneumonia, bacteremia, septicemia, bronchitis,
T212	adversereaction 33615 33631	skin infections)
T213	adversereaction 33637 33673	infusion reactions, asthenia, fever,
T214	adversereaction 33678 33684	nausea
T215	tradename 33819 33825	BEXXAR
T216	adversereaction 33855 33898	severe and prolonged cytopenias, infections
T217	adversereaction 33910 33920	pneumonia,
T218	adversereaction 33925 33960	bacteremia, septicemia, bronchitis,
T219	adversereaction 33965 33981	skin infections)
T220	adversereaction 33983 34009	serious allergic reactions
T221	adversereaction 34025 34037	bronchospasm
T222	adversereaction 34042 34053	angioedema)
T223	adversereaction 34055 34074	infusion reactions,
T224	adversereaction 34079 34097	secondary leukemia
T225	adversereaction 34106 34130	myelodysplastic syndrome
T226	tradename 34572 34578	BEXXAR
T227	indication 34624 34646	non-Hodgkin's lymphoma
T228	tradename 35963 35969	BEXXAR
T229	adversereaction 36085 36093	Asthenia
T230	adversereaction 36101 36106	Fever
T231	adversereaction 36116 36126	Infectiona
T232	adversereaction 36138 36142	Pain
T233	adversereaction 36150 36156	Chills
T234	adversereaction 36164 36172	Headache
T235	adversereaction 36182 36196	Abdominal pain
T236	adversereaction 36205 36214	Back pain
T237	adversereaction 36222 36232	Chest pain
T238	adversereaction 36240 36249	Neck pain
T239	adversereaction 36286 36297	Hypotension
T240	adversereaction 36304 36318	Vasodilatation
T241	adversereaction 36350 36356	Nausea
T242	adversereaction 36366 36374	Vomiting
T243	adversereaction 36382 36390	Anorexia
T244	adversereaction 36398 36406	Diarrhea
T245	adversereaction 36414 36426	Constipation
T246	adversereaction 36433 36442	Dyspepsia
T247	adversereaction 36477 36491	Hypothyroidism
T248	adversereaction 36499 36534	Metabolic and Nutritional Disorders
T249	adversereaction 36543 36559	Peripheral edema
T250	adversereaction 36567 36578	Weight loss
T251	adversereaction 36659 36666	Myalgia
T252	adversereaction 36680 36690	Arthralgia
T253	adversereaction 36721 36730	Dizziness
T254	adversereaction 36738 36748	Somnolence
T255	adversereaction 36782 36797	Cough increased
T256	adversereaction 36806 36817	Pharyngitis
T257	adversereaction 36825 36832	Dyspnea
T258	adversereaction 36840 36848	Rhinitis
T259	adversereaction 36858 36867	Pneumonia
T260	adversereaction 36902 36906	Rash
T261	adversereaction 36918 36926	Pruritus
T262	adversereaction 36934 36942	Sweating
T263	adversereaction 38575 38607	Prolonged and Severe Cytopenias:
T264	adversereaction 38979 38990	Infections:
T265	adversereaction 39129 39151	pneumonia, bacteremia,
T266	adversereaction 39156 39179	septicemia, bronchitis,
T267	adversereaction 39184 39200	skin infections.
T268	adversereaction 39205 39243	Allergic (Hypersensitivity) Reactions:
T269	adversereaction 39331 39396	allergic reaction, facial edema, injection site hypersensitivity,
T270	adversereaction 39401 39436	anaphylactic reaction, laryngismus,
T271	adversereaction 39441 39456	serum sickness.
T272	adversereaction 39497 39515	Infusion reactions
T273	adversereaction 39526 39539	fever, rigors
T274	adversereaction 39543 39550	chills,
T275	adversereaction 39555 39600	sweating, hypotension, dyspnea, bronchospasm,
T276	adversereaction 39605 39611	nausea
T277	adversereaction 39948 39972	Myelodysplastic Syndrome
T278	adversereaction 39979 39998	Secondary Leukemia:
T279	nanoparticle 41946 41958	tositumomab.
T280	indication 42578 42600	Non-Hodgkin's Lymphoma
T281	tradename 42615 42621	BEXXAR
T282	indication 42953 42975	non-Hodgkin's lymphoma
T283	tradename 42997 43003	BEXXAR
T284	tradename 43439 43445	BEXXAR
T285	tradename 43646 43652	BEXXAR
T286	nanoparticle 44137 44148	tositumomab
T287	nanoparticle 44152 44174	I-131 499 tositumomab.
T288	tradename 44324 44330	BEXXAR
T289	tradename 44453 44459	BEXXAR
T290	activeingredient 44674 44679	I-131
T291	tradename 44757 44763	BEXXAR
T292	tradename 44881 44887	BEXXAR
T293	nanoparticle 45151 45162	tositumomab
T294	tradename 45423 45429	BEXXAR
T295	tradename 45575 45581	BEXXAR
T296	tradename 45683 45689	BEXXAR
T297	tradename 45807 45813	BEXXAR
T298	tradename 46026 46032	BEXXAR
T299	tradename 46354 46360	BEXXAR
T300	tradename 46561 46567	BEXXAR
T301	tradename 46818 46824	BEXXAR
T302	tradename 46914 46920	BEXXAR
T303	activeingredient 47061 47067	I-131,
T304	tradename 47072 47078	BEXXAR
T305	activeingredient 47350 47355	I-131
T306	tradename 47373 47379	BEXXAR
T307	tradename 47673 47679	BEXXAR
T308	tradename 47733 47739	BEXXAR
T309	nanoparticle 47803 47815	tositumomab,
T310	nanoparticle 47858 47876	I-131 tositumomab.
T311	nanoparticle 47881 47892	Tositumomab
T312	nanoparticle 48042 48053	tositumomab
T313	molecularweight 48057 48068	150 559 kD.
T314	nanoparticle 48073 48084	Tositumomab
T315	routeofadministration 48235 48246	intravenous
T316	inactiveingredient 48302 48310	maltose,
T317	inactiveingredient 48321 48337	sodium chloride,
T318	inactiveingredient 48346 48356	phosphate,
T319	inactiveingredient 48369 48389	potassium hydroxide,
T320	inactiveingredient 48394 48399	Water
T321	nanoparticle 48453 48470	I-131 tositumomab
T322	nanoparticle 48474 48485	tositumomab
T323	activeingredient 48507 48518	Iodine-131.
T324	nanoparticle 48519 48536	I-131 tositumomab
T325	nanoparticle 48620 48637	I-131 tositumomab
T326	inactiveingredient 48668 48682	ascorbic acid,
T327	inactiveingredient 48696 48703	maltose
T328	inactiveingredient 48743 48750	maltose
T329	inactiveingredient 48790 48799	povidone,
T330	inactiveingredient 48821 48841	sodium 568 chloride.
T331	activeingredient 48921 48943	Iodine-131: Iodine-131
T332	activeingredient 49207 49217	Iodine-131
T333	activeingredient 49429 49439	Iodine-131
T334	activeingredient 49664 49675	Iodine-131:
T335	activeingredient 49934 49945	Tositumomab
T336	indication 50154 50178	non-Hodgkin's lymphomas.
T337	tradename 50291 50297	BEXXAR
T338	tradename 50807 50813	BEXXAR
T339	tradename 51549 51555	BEXXAR
T340	nanoparticle 51689 51706	I-131 tositumomab
T341	dose 51725 51731	475-mg
T342	dose 51920 51926	485 mg
T343	nanoparticle 51934 51945	tositumomab
T344	indication 51967 51990	non-Hodgkin's lymphomas
T345	clearance 51995 52005	68.2 mg/hr
T346	clearance 52014 52038	30.2 to 611 260.8 mg/hr)
T347	indication 52715 52737	non-Hodgkin's lymphoma
T348	eliminationhalflife 52742 52750	67 hours
T349	eliminationhalflife 52759 52775	28 to 115 hours)
T350	activeingredient 52796 52806	Iodine-131
T351	tradename 53239 53245	BEXXAR
T352	activeingredient 53341 53353	Iodine I-131
T353	tradename 53420 53426	BEXXAR
T354	tradename 53591 53597	BEXXAR
T355	tradename 55036 55042	BEXXAR
T356	indication 55735 55757	non-Hodgkin's lymphoma
T357	tradename 56048 56054	BEXXAR
T358	nanoparticle 56761 56772	tositumomab
T359	nanoparticle 56916 56937	I-131 669 tositumomab
T360	nanoparticle 57242 57253	tositumomab
T361	nanoparticle 57408 57428	I677 131 tositumomab
T362	nanoparticle 57565 57577	Tositumomab:
T363	nanoparticle 57619 57630	tositumomab
T364	nanoparticle 57752 57763	tositumomab
T365	nanoparticle 57905 57923	I-131 tositumomab:
T366	nanoparticle 57939 57956	I-131 tositumomab
T367	nanoparticle 58112 58129	I-131 tositumomab
T368	nanoparticle 58238 58259	I-131 689 tositumomab
T369	tradename 59410 59416	BEXXAR
T370	tradename 59684 59690	BEXXAR
T371	tradename 60105 60111	BEXXAR
T372	tradename 60233 60239	BEXXAR
T373	tradename 60312 60318	BEXXAR
T374	company 60348 60364	GlaxoSmithKline.
T375	company 60440 60455	GlaxoSmithKline
T376	company 60526 60542	GlaxoSmithKline.
